Herbert Wiedemann, M.D.
| Appointed: |
1984 |
| Gender: |
Male |
| Languages: |
English |
Pulmonary, Allergy and Critical Care Medicine
Co-Director, Asthma Center
Biographical Sketch
Herbert P. Wiedemann, MD, MBA, is Chairman of the Cleveland Clinic Respiratory Institute as well as Chairman of the Department of Pulmonary, Allergy & Critical Care Medicine, a position he has held since 1991. Dr. Wiedemann also served a five-year term on Cleveland Clinic's Board of Governors (2001-2006).
He is board-certified in internal medicine, pulmonary disease, and critical care medicine, Dr. Wiedemann's clinical interests are intensive care medicine (including acute respiratory distress syndrome and sepsis) and the evaluation of dyspnea (including cardiopulmonary exercise testing).
Dr. Wiedemann has been the recipient of many awards including The Best Doctors in America, America's Top Doctors, Who's Who in Medicine and Healthcare, and Who's Who in America. Dr. Wiedemann has participated in several large multicenter trials of new therapies for acute respiratory distress syndrome (ARDS) and sepsis, and he served as principal investigator for three of these trials.
In addition, Dr. Wiedemann is a journal reviewer for many peer-reviewed publications including New England Journal of Medicine, Annals of Internal Medicine, Chest, European Respiratory Journal, and Journal of Intensive Care Medicine. He is a member or fellow of the American College of Chest Physicians, the American College of Critical Care Medicine and the American College of Physicians. Dr. Wiedemann also has taught as a visiting professor at many national and international universities.
After receiving his B.S degree from Yale, and medical degree from Cornell University College of Medicine in New York City, Dr. Wiedemann completed his internship and residency in internal medicine at the University of Washington Medical Center in Seattle, where he also served as chief medical resident. He completed his fellowship in pulmonary and critical care medicine at Yale University in Haven Hospital in Connecticut. Dr. Wiedemann has also received an M.B.A. degree from the Yale University School of Management.
Education & Fellowships
| Medical School: | Cornell University Medical College, New York, NY |
|
| Internship: | University of Washington Medical Center, Medicine, Seattle, WA |
| Residency: | Harborview Medical Center, IM Chief Resident, Seattle, WA |
| Residency: | University of Washington Medical Center, Internal Medicine, Seattle, WA |
| Fellowship: | Yale-New Haven Hospital, Pulmonary, New Haven, CT |
| Other Education: | (Graduate) Yale University, New Haven, CT |
| Other Education: | (Undergraduate) Yale University, New Haven, CT |
Certifications
Pulmonary Disease
Internal Medicine
Specialty Interests
Intensive care (including adult respiratory distress syndrome and sepsis), exercise testing, lung cancer, interstitial lung disease, fiberoptic bronchoscopy, pleural effusions.
Awards & Honors
- Dr. Wiedemann is included in "The Best Doctors in America" (Woodward/White, Inc.) since 1992, "America's Top Doctors" (Castle Connolly Medical. LTD.) since 2001, "Who's Who in America" (Marquis, Inc.) since 1997, and "Who's Who in the World" (Marquis, Inc) since 1998.
- Dr. Wiedemann has received continuous funding from the National Institutes of Health (NIH) since 1994 in his role as site Principal Investigator at the Cleveland Clinic for participation in the Acute Respiratory Distress Syndrome (ARDS) Clinical Trial Network.
Professional Memberships
- Fellow, American College of Physicians
- Fellow, American College of Chest Physicians
- Fellow, American College of Critical Care Medicine
- American Thoracic Society
- American College of Physician Executives
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/31/2008, Dr. Wiedemann has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Wiedemann receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
- Agennix
- Eisai Medical Research Inc.
- Takeda
Equity. Dr. Wiedemann owns stock or stock options in the following companies for activities as a founder, inventor, or consultant:
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)